AzTrials
AzTrials

Dynamic Lung CompliancePEEPNCT07494240

Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopic Sleeve Gastrectomy

A study testing incremental peep in people with Dynamic Lung Compliance, run by Beni-Suef University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this prospective intervention study is to determine whether individualized positive end expiratory pressure (PEEP) titration targeting the minimum Driving pressure (ΔP) during LGS operation improves intraoperative pulmonary dynamic compliance (Cdyn), oxygenation, post operative pulmonary complication… Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Dynamic Lung Compliance
What is being tested?
incremental peep
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteEgypt
Study dates
15 Apr 2026to 15 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • BMI 35 -40kg·m-²
  • ASA II-III
  • Elective primary laparoscopic sleeve gastrectomy

Who cannot join

  • Patient refusing consent
  • ASA IV patients.
  • Sever pulmonary disease
  • Sever obstructive sleep apnea (OSA)
  • Hepatic or cardic or renal imparment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Eman G Radwan, master contact

+201278555771

eman_gamal1@hotmail.com

Samaa A Rashwan, Professor contact

+201270159125

samaarashwan1971@gmail.com

Egypt1 site
  • Beni-Suef University Hospital

    Banī Suwayf, Beni Suweif Governorate, 62511

    Eman G Radwan, master, +201278555771, eman_gamal1@hotmail.com

    Samaa A Rashwan, Professor, +201270159125, samaarashwan1971@gmail.com

Other trials in Egypt

About this study

Official title: Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Patients Undergoing Laparoscopic Sleeve Gastrectomy

The goal of this prospective intervention study is to determine whether individualized positive end expiratory pressure (PEEP) titration targeting the minimum Driving pressure (ΔP) during LGS operation improves intraoperative pulmonary dynamic compliance (Cdyn), oxygenation, post operative pulmonary complication (PPCS) Participants will be assigned to two group (incremental - fixed )peep group Researchers will compare the two group to see if peep titration improve lung compliance, lung mechanics intraopertive and PPCS

Read the detailed description

Obesity (BMI \ge 30 kg/m^2) significantly increases the risk of atelectasis and respiratory dysfunction under anesthesia. During Laparoscopic Sleeve Gastrectomy (LSG), the combination of pneumoperitoneum and the Trendelenburg position further impairs lung compliance. Standard lung-protective strategies often use a fixed PEEP, which may be insufficient for obese patients or cause hemodynamic instability if set too high.

Fixed PEEP (usually 5 cmH_2O) does not account for individual variations in chest wall mechanics during laparoscopy.

This prospective, randomized, double-blind study involving 46 patients (20-60 years old, BMI 35-40 kg/m^2).

The Intervention

  • Control Group: Receives a fixed PEEP of 5 cmH_ throughout the procedure.
  • Intervention Group: Receives individualized PEEP titration. After a recruitment maneuver, PEEP is adjusted (from 3 to 12 cmH_2O) to identify the level that achieves the minimum Driving Pressure . This optimal PEEP is then maintained for the surgery.

Key Outcomes

  • Primary: Dynamic pulmonary compliance measured 10 minutes after pneumoperitoneum cessation (T3).
  • Secondary: Oxygenation (PaO_2/FiO_2 ratio), driving pressure levels, postoperative pulmonary complications (PPCs) within 48 hours, and length of hospital stay.
Being tested
incremental peep

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • incremental peepOther

    PEEP will be gradually increased by 1 cmH2O starting from the lowest PEEP allowed by the anesthesia machine (3 cmH2O) to 12 cmH2O, and each PEEP level will be maintained for 10 respiratory cycles and the driving pressure values will be recorded. When driving pressure increased with increasing PEEP, downward PEEP titration will be per- formed until the minimum driving pressure appears

Study groups in NCT07494240
Study groupRoleWhat they receive
incremental peepActive comparatorafter the pneumo- peritoneum- anti Trendelenburg position is established and RM is performed. PEEP will be gradually increased by 1 cmH2O starting from the lowest PEEP allowed by the anesthesia machine (3 cmH2O) to 12 cmH2O, and each PEEP level will be maintained for 10 respiratory cycles and the driving pressure values will be recorded. When driving pressure increased with increasing PEEP, downward PEEP titration will be per- formed until the minimum driving pressure appears. this optimal individualized PEEP will be maintained throughout the procedure.
Receives: Other: incremental peep
fixed peepNo interventionFixed PEEP = 5 cmH₂O through surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. dynamic pulmonary compliance

    Measurement of the lung's ability to stretch and expand during mechanical ventilation, calculated 10 minutes after the cessation of pneumoperitoneum. This measures the impact of individualized PEEP versus fixed PEEP on respiratory mechanics after the main surgical stressor is removed

    Measured: Recorded at T3 (10 minutes after pneumoperitoneum cessation).

Secondary outcomes (3)
  1. Oxygenation Ratio (PaO_2/FiO_2)

    Assessed via arterial blood gas analysis to evaluate gas exchange efficiency.

    Measured: Recorded at T0(10 minutes after tracheal intubation), , T2(1 hour after pneumoperitoneum establishment), and T4 (15 minutes after extubation).

  2. Driving Pressure

    Calculated as Plateau pressure minus PEEP.

    Measured: Recorded at T0 (10 minutes after intubation), T1 (10 minutes after pneumoperitoneum), T2 (1 hour after pneumoperitoneum), and T3 (10 minutes after pneumoperitoneum cessation).

  3. Postoperative Pulmonary Complications (PPCs)

    Incidence of hypoxia, bronchospasm, or chest infections (cough, fever, expectoration).

    Measured: Within 48 hours postoperatively.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2026
  2. Study start15 Apr 2026 (estimated)
  3. Primary completion15 Sep 2027 (estimated)
  4. Study completion15 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a prospective, randomized, double-blinded, parallel-group study. Patients are randomly assigned in a 1:1 ratio to either the intervention or control group using a computer-generated sequence. * Intervention Group (DP Group): Following a recruitment maneuver, PEEP is titrated incrementally (by 1 cmH) to identify and maintain the minimum Driving Pressure . * Control Group (Fixed Group): Patients receive a standard fixed PEEP of 5 cmH\_2O throughout the procedure. * Standardization: Both groups receive volume-controlled ventilation (V\_T 8 ml/kg IBW) and identical anesthetic protocols. * Objective: To compare the effects of individualized versus fixed PEEP on dynamic lung compliance (C\_{dyn}) and oxygenation (PaO\_2/FiO\_2) during laparoscopic sleeve gastrectomy.
Masking
Single blind
Who is masked
Participant
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07494240
Sponsor's protocol ID
FMBSUREC/06012026/Radwan
Acronym
PEEP
Status last verified
Mar 2026
First submitted
15 Mar 2026
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing incremental peep in people with Dynamic Lung Compliance, run by Beni-Suef University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eman G Radwan, master (+201278555771, eman_gamal1@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

dynamic pulmonary compliance (time frame: Recorded at T3 (10 minutes after pneumoperitoneum cessation).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in